Clinical Trial: Intratumoral PH-762 for Cutaneous Carcinoma
Study Status: Completed
Recruit Status: RECRUITING
Condition: Squamous Cell Carcinoma of the Skin
Study Type: INTERVENTIONAL
Official Title: Dose Escalation Study of Neoadjuvant Intratumoral PH-762 for Cutaneous Squamous Cell Carcinoma, Melanoma, or Merkel Cell Carcinoma
Brief Summary:
The goal of this clinical trial is to evaluate the safety and tolerability of intratumoral injections of PH-762 in squamous cell carcinoma, melanoma, or Merkel cell carcinomas of the skin, to understand what the body does to the PH-762, and to observe how the tumor responds to the drug.Participants will receive four injections of PH-762 at weekly intervals, into a single tumor, followed by surgical removal of the tumor approximately two weeks later.
Read more